In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order 2013

jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 3690] ubZ fnYyh] c`gLifrokj] uoEcj 14] 2019@dkfrZd 23] 1941 No. 3690] NEW DELHI, THURSDAY, NOVEMBER 14, 2019/KARTIKA 23, 1941 jlk;u vkSj moZjd ea=ky; ¼vkS"k/k foHkkx½ ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ vvvvkkkknnnn’’ss’’ss kkkk ub Z fnYyh] 14 uoEcj] 2019 ddddkkkk----vvvvkkkk---- 4444111100003333¼¼¼¼vvvv½½½½----&&&&Hkkjr ljdkj d s jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 eb]Z 2013 vkSj dk-vk- 701¼v½ rkjh[k 10 ekp]Z 2016 d s lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk inz Rr 'kfDr;k sa dk i;z kxs djrs g,q ] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldk s lfa{kIr :i e sa ,uihih, dgk tkrk g½S] uhp s dh lkj.kh d s LrHa k ¼6½ e as fofufn"ZV [knq jk ewY; dk s mDr lkj.kh d s LrHa k ¼3½] ¼4½] vkSj ¼5½ e as rRLFkkuh ifzof"V;ksa e sa fofufn"ZV icz yrk] bdkb Z ¼;wfuV½ vkSj fofuekZrk vkSj foi.ku dEifu;k sa d s uke lfgr LrHa k ¼2½ e sa dh rRLFkkuh izfof"V es a l s iRz ;ds dh] oLr q ,o a lsok dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre [knq jk ewY; d s :i e sa fu;r djrh gSA lkj.kh Øz- vuqlwfpr fofufeZfr izcyrk bdkbZ fofuekZrk vkSj foi.ku [kqnjk la- dk uke@czkaM dk daiuh ewY; uke ¼#-½ (1) (2) (3) (4) (5) (6) 1. Q~ywdksuktksy xksyh izR;sd vfyfir xksyh esa% 1 xksyh eSllZ LdkbZesi 16.16 Q~ywdksuktksy vkbZih 300 fexzk- QkekZL;wfVdYl izk- fy- 2. ,VksjokLVkVhu $ izR;sd gkMZ tsysVkbu dSIlwy esa% 5.27 ,fLifju $ ,VksjokLVkVhu dSfY’k;e vkbZih ds cjkcj DyksfiMksxzsy dSIlwy ,VksjokLVkfVu 20 fexzk- ¼Vw okbV dkykWMZ fQYe fyfir xksfy;ka] izR;sd 10 fexzk- ,VksjokLVkfVu vkbZih xksfy;ksa esa½] eSllZ foaMykl ck;ksVsd ,fLifju vkbZih 75 fexzk- ¼,aVªhd fyfir okbV 1 dSIlwy izk- fy-@eSllZ esudkbaM dkykWMZ isysVl esa½] QkekZ fy- DyksihMksxzsy ckblYQsV vkbZih ds cjkcj DyksihMksxzsy 75 fexzk- ¼Vw czkmu dkykWMZ fQYe fyfir] izR;sd 37-5 fexzk- DyksihMksxzsy xksyh esa½ 5884 GI/2019 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 3. ,VksjokLVkVhu $ izR;sd gkMZ tsysVkbu dSIlwy esa% 1 dSIlwy 3.80 ,fLifju $ ,VksjokLVkVhu dSfY’k;e vkbZih ds cjkcj eSllZ lk;uksdse DyksfiMksxzsy dSIlwy ,VksjokLVkfVu 10 fexzk- ¼isysVl esa½] QkekZL;wfVdYl fy-@eSllZ DyksihMksxzsy ckblYQsV vkbZih ds cjkcj ,eD;ksj QkekZL;wfVdYl DyksihMksxzsy 75 fexzk- ¼isysVl esa½] fy- ,fLifju vkbZih 75 fexzk- ¼,aVªhd fyfir isysVl esa½] 4. ,VksjokLVkVhu $ izR;sd gkMZ tsysVkbu dSIlwy esa% 1 dSIlwy 5.27 ,fLifju $ ,VksjokLVkVhu dSfY’k;e vkbZih ds cjkcj eSllZ lk;uksdse DyksfiMksxzsy dSIlwy ,VksjokLVkfVu 20 fexzk- ¼isysVl esa½] QkekZL;wfVdYl fy-@eSllZ DyksihMksxzsy ckblYQsV vkbZih ds cjkcj ,eD;ksj QkekZL;wfVdYl DyksihMksxzsy 75 fexzk- ¼isysVl esa½] fy- ,fLifju vkbZih 75 fexzk- ¼,aVªhd fyfir isysVl esa½] 5. ,VksjokLVkVhu $ izR;sd gkMZ tsysVkbu dSIlwy esa% 1 dSIlwy 3.80 ,fLifju $ ,VksjokLVkVhu dSfY’k;e vkbZih ds cjkcj DyksfiMksxzsy dSIlwy ,VksjokLVkfVu 10 fexzk- ¼isysVl esa½] EkSllZ lk;uksdse DyksihMksxzsy ckblYQsV vkbZih ds cjkcj QkekZL;wfVdYl fy-@eSllZ DyksihMksxzsy 75 fexzk- ¼isysVl esa½] lhiyk fy- ,fLifju vkbZih 75 fexzk- ¼,aVªhd fyfir isysVl esa½ 6. ,VksjokLVkVhu $ izR;sd gkMZ tsysVkbu dSIlwy esa% 5.27 ,fLifju $ ,VksjokLVkVhu dSfY’k;e vkbZih ds cjkcj DyksfiMksxzsy dSIlwy ,VksjokLVkfVu 20 fexzk- ¼isysVl esa½] EkSllZ lk;uksdse DyksihMksxzsy ckblYQsV vkbZih ds cjkcj 1 dSIlwy QkekZL;wfVdYl fy-@eSllZ DyksihMksxzsy 75 fexzk- ¼isysVl esa½] lhiyk fy- ,fLifju vkbZih 75 fexzk- ¼,aVªhd fyfir isysVl esa½ 7. foYMkXyhIVhu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ esMhQkslZ gsYFkds;j 22.77 esVQksfeZu xksyh foYMkXyhIVhu 50 fexzk-] izk- fy-@eSllZ esudkbaM esVQksfeZu gkbMªksDyksjkbM 500 fexzk- QkekZ fy- 8. foYMkXyhIVhu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ,DlsesM 12.26 esVQksfeZu xksyh foYMkXyhIVhu 50 fexzk-] QkekZL;wfVdYl @eSllZ (foMkyksx ,e 500) esVQksfeZu gkbMªksDyksjkbM 500 fexzk- oksdkMZ fy- 9. foYMkXyhIVhu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ esMhQkslZ gsYFkds;j 22.75 esVQksfeZu xksyh + foYMkXyhIVhu 50 fexzk-] izk- fy-@eSllZ esudkbaM esVQksfeZu gkbMªksDyksjkbM 850 fexzk- QkekZ fy- 10. foYMkXyhIVhu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ,DlsesM 12.26 esVQksfeZu xksyh foYMkXyhIVhu 50 fexzk-] QkekZL;wfVdYl @eSllZ (foMykWx ,e 850) esVQksfeZu gkbMªksDyksjkbM 850 fexzk- oksdMZ fy- 11. foYMkXyhIVhu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ esMhQkslZ gsYFkds;j 23.40 esVQksfeZu xksyh foYMkXyhIVhu 50 fexzk-] izk- fy-@eSllZ esudkbaM esVQksfeZu gkbMªksDyksjkbM 1000 fexzk- QkekZ fy- 12. foYMkXyhIVhu $ izR;sd fQYe fyfir xksyh esa% 1 xksyh eSllZ ,DlsesM 12.53 esVQksfeZu xksyh foYMkXyhIVhu 50 fexzk-] QkekZL;wfVdYl @eSllZ (foMykWx ,e 1000) esVQksfeZu gkbMªksDyksjkbM 1000 fexzk- oksdkMZ fy- uksV % ¼d½ mi;qZDr nh xbZ fofufnZ"V QkWewZys'ku ds fofuekZrk vFkkZr tks ÞubZ Mªxß Mhihlhvks] 2013 ds iSjkxzkQ 2¼;w½ ds rgr mi;qZDr nh xbZ lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (6) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq ,oa lsok dj dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls ,d ewY; lwph ,uihih, dks vkbZihMh,e,l ds ek/;e ls tkjh djsa rFkk mldh dkiWh jkT; vkS"kf/k fu;a=dksa vkSj fofuekZrk forjdksa dks tkjh djsaA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds 24 (4) ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls ifjlj] tgka dkjckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’; Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA¹Hkkx IIµ[k.M 3(ii)] Hkkjr dk jkti=k % vlk/kj.k 3 ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr vuqc) ewY; fu/kkZj.k@la'kks/ku ds fy, QkWeZ I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkZfjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds vUrxZr tSlk fd dsUnzh;@jkT; ykblsflax vkWFkksfjVh ds l{ke izkf/kdkjh }kjk esU;wQsDpfjax ykblsal eatwjh ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufeZfr;ksa vkSj fofufnZ"V 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼N½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA [dka-la-@202@70/2019@,Q@Qk- la- 8¼70½@2019@Mhih@,uihih,&fMoh--II] izlsuthr nkl] lgk;d funs'kd MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 14th November, 2019 S.O. 4103(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O.701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE Sl. Name of the Strength Unit Manufacturer & Retail No. Formulation / Brand Marketing Company Price Name (Rs.) (1) (2) (3) (4) (5) (6) 1. Fluconazole Tablet Each uncoated tablet contains: M/s Skymap 16.16 1 Tablet Fluconazole IP 300mg Pharmaceuticals Pvt. Ltd. 2. Atorvastatin + Aspirin Each hard gelatine capsule contains: 5.27 + Clopidogrel Capsule Atorvastatin Calcium IP eq. to Atorvastatin 20mg (As two white coloured film coated tablets, each containing 10mg Atorvastatin Tablets IP), M/s Windlas Biotech Pvt. Aspirin IP 75mg (As enteric coated white 1 Capsule Ltd. / M/s Mankind coloured pellets) Pharma Limited Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets, Each containing 37.5mg Clopidogrel tablet IP) 3. Atorvastatin + Aspirin Each hard gelatine capsule contains: 3.80 + Clopidogrel Capsule Atorvastatin Calcium IP eq. to Atorvastatin M/s Synokem 10mg (As Pellets), Pharmaceuticals Ltd. / 1 Capsule Clopidogrel Bisulphate IP eq. to Clopidogrel M/s Emcure 75mg (As Pellets) Pharmaceuticals Limited Aspirin IP 75mg (As enteric coated pellets)4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 4. Atorvastatin + Aspirin Each hard gelatine capsule contains: 5.27 + Clopidogrel Capsule Atorvastatin Calcium IP eq. to Atorvastatin M/s Synokem 20mg (As Pellets), Pharmaceuticals Ltd. / 1 Capsule Clopidogrel Bisulphate IP eq. to Clopidogrel M/s Emcure 75mg (As Pellets) Pharmaceuticals Limited Aspirin IP 75mg (As enteric coated pellets) 5. Atorvastatin + Aspirin Each hard gelatine capsule contains: 3.80 + Clopidogrel Capsule Atorvastatin Calcium IP eq. to Atorvastatin M/s Synokem 10mg (As Pellets), 1 Capsule Pharmaceuticals Ltd. / Clopidogrel Bisulphate IP eq. to Clopidogrel M/s Cipla Limited 75mg (As Pellets) Aspirin IP 75mg (As enteric coated pellets) 6. Atorvastatin + Aspirin Each hard gelatine capsule contains: 5.27 + Clopidogrel Capsule Atorvastatin Calcium IP eq. to Atorvastatin M/s Synokem 20mg (As Pellets), 1 Capsule Pharmaceuticals Ltd. / Clopidogrel Bisulphate IP eq. to Clopidogrel M/s Cipla Limited 75mg (As Pellets) Aspirin IP 75mg (As enteric coated pellets) 7. Vildagliptin + Each film coated Tablet contains: M/s Mediforce Healthcare 22.77 Metformin Tablet Vildagliptin 50mg, 1 Tablet Pvt. Ltd. / M/s Mankind Metformin Hydrochloride IP 500mg, Pharma Limited 8. Vildagliptin + Each film coated Tablet contains: M/s Exemed 12.26 Metformin Tablet Vildagliptin 50mg, 1 Tablet Pharmaceuticals / M/s (Vidalog M 500) Metformin Hydrochloride IP 500mg, Wockhardt Limited 9. Vildagliptin + Each film coated Tablet contains: M/s Mediforce Healthcare 22.75 Metformin Tablet Vildagliptin 50mg, 1 Tablet Pvt. Ltd. / M/s Mankind Metformin Hydrochloride IP 850mg, Pharma Limited 10. Vildagliptin + Each film coated Tablet contains: M/s Exemed 12.26 Metformin Tablet Vildagliptin 50mg, 1 Tablet Pharmaceuticals / M/s (Vidalog M 850) Metformin Hydrochloride IP 850mg, Wockhardt Limited 11. Vildagliptin + Each film coated Tablet contains: M/s Mediforce Healthcare 23.40 Metformin Tablet Vildagliptin 50mg, 1 Tablet Pvt. Ltd. / M/s Mankind Metformin Hydrochloride IP 1000mg, Pharma Limited 12. Vildagliptin + Each film coated Tablet contains: M/s Exemed 12.53 Metformin Tablet Vildagliptin 50mg, 1 Tablet Pharmaceuticals / M/s (Vidalog M 1000) Metformin Hydrochloride IP 1000mg, Wockhardt Limited Note: (a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit¹Hkkx IIµ[k.M 3(ii)] Hkkjr dk jkti=k % vlk/kj.k 5 the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [PN/202/70/2019/F/ F. No. 8(70)/2019/D.P./NPPA-Div.-II ] PRASENJIT DAS, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.